Drug shortages

Bumetanide Injection

Mullan Pharmaceutical Inc.

Resolved83301-0081-2Cardiovascular
Open FDA's page for this record
Update type
Revised
Initial posting date
12/13/2017
Change date
09/30/2026
Package NDC
83301-0081-2
Generic name
Bumetanide Injection
Contact info
800-673-9839
Resolved note
Available
Update date
09/30/2026
Dosage form
Injection
Presentation
Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)
Company name
Mullan Pharmaceutical Inc.
Status
Resolved
Therapeutic category
Cardiovascular
Harmonized identifiers (openFDA)
Application number
ANDA219116
Brand name
BUMETANIDE
Generic name
BUMETANIDE
Manufacturer name
Mullan Pharmaceutical Inc.
Product NDC
83301-0081, 83301-0080
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAMUSCULAR, INTRAVENOUS
Substance name
BUMETANIDE
RxCUI
282486, 1727569
SPL ID
4c241a3e-649b-4414-e063-6294a90a3a32
SPL set ID
b7cd724b-817b-4b45-8133-1ebf505867e7
Package NDC
83301-0080-1, 83301-0080-2, 83301-0081-1, 83301-0081-2
Nui
N0000175366, N0000175590
Pharm class pe
Increased Diuresis at Loop of Henle [PE]
Pharm class epc
Loop Diuretic [EPC]
UNII
0Y2S3XUQ5H
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.